Findings from a recent study published in the journal JAMDA demonstrate that antipsychotic medications increase the risk…
Ana de Barros, PhD
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana de Barros, PhD
In a recent study published in the journal Molecular Neurodegeneration, a team of researchers from the Imperial College London…
Parkinson’s Disease Foundation Launches Women and PD Initiative to Urge Local Communities Involvment
The country’s first coordinated initiative geared towards enhancing the holistic health of women diagnosed with Parkinson’s disease was officially launched last…
Ultra-athlete Sam Fox went through three long and back-breaking months, hiking, climbing and biking across the United States, all for…
Everyday Activity More Beneficial Than Occasional Vigorous Exercise in Parkinson’s Disease Patients
Results from a recent study published in the journal Parkinsonism & Related Disorders showed that individuals with…
ACADIA Pharmaceuticals Files New Drug Application for NUPLAZID In Parkinson’s Disease Psychosis
ACADIA Pharmaceuticals Inc., a biopharmaceutical company specialized in the development and commercialization of innovative medicines to address unmet medical needs in…
Neuroscientists from the University of Adelaide are leading a first-of-its-kind study on a type of dementia commonly observed in patients…
The National Parkinson Foundation’s (NPF) medical director, Michael S. Okun, M.D., recently published a new book, titled, “10 Breakthrough Therapies for Parkinson’s…
The Lawson Health Research Institute recently signed a licensing agreement with STEMCELL Technologies to transfer international exclusive rights to commercialize innovative…
The battle against Parkinson’s disease may be getting sweeter, with a new study underway seeking to understand if concentrated chocolate supplements could help…